245 related articles for article (PubMed ID: 17396618)
1. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Ito T
Arzneimittelforschung; 2003; 53(10):714-21. PubMed ID: 14650364
[TBL] [Abstract][Full Text] [Related]
3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
4. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
[TBL] [Abstract][Full Text] [Related]
5. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
7. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
[TBL] [Abstract][Full Text] [Related]
9. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
[TBL] [Abstract][Full Text] [Related]
10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.
Asano K; Shiomi T; Hasegawa N; Nakamura H; Kudo H; Matsuzaki T; Hakuno H; Fukunaga K; Suzuki Y; Kanazawa M; Yamaguchi K
Pharmacogenetics; 2002 Oct; 12(7):565-70. PubMed ID: 12360108
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
[TBL] [Abstract][Full Text] [Related]
13. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Horiguchi T; Hayashi N; Ohira D; Torigoe H; Ito T; Hirose M; Sasaki Y; Shiga M; Miyazaki J; Kondo R; Tachikawa S
J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
[TBL] [Abstract][Full Text] [Related]
15. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.
Chalmers GW; Macleod KJ; Little SA; Thomson LJ; McSharry CP; Thomson NC
Thorax; 2002 Mar; 57(3):226-30. PubMed ID: 11867826
[TBL] [Abstract][Full Text] [Related]
16. Pranlukast: a review of its use in the management of asthma.
Keam SJ; Lyseng-Williamson KA; Goa KL
Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
[TBL] [Abstract][Full Text] [Related]
17. Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone.
Shiga M; Horiguchi T; Kondo R; Miyazaki J; Hirose M; Otake Y; Hata H; Tachikawa S
Asian Pac J Allergy Immunol; 2011 Jun; 29(2):134-42. PubMed ID: 21980828
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.
Belda J; Margarit G; Martínez C; Bellido-Casado J; Casan P; Torrejón M; Brufal M; Rodríguez-Jerez F; Sanchis J
Eur Respir J; 2007 Dec; 30(6):1143-9. PubMed ID: 17690122
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
